26 May 2023 : Case report
RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101
Unknown etiology, Educational Purpose (only if useful for a systematic review or synthesis)
Jessica M. Goss1BCDF*, Pamela Hair1ABCDF, Parvathi S. Kumar1ADEF, Ulrich Thienel1AG, Kenji Cunnion1ACDEFG, Alexander Ellis2AEDOI: 10.12659/AJCR.939803
Am J Case Rep 2023; 24:e939803
Table 1. Subject 1504 abnormal biochemistry and urinalysis results.
Category | Test (unit) | Visit | Result (flag) | Clinical significance | Normal reference range |
---|---|---|---|---|---|
General biochemistry | Protein (g/L) | Screening | 71 | 63–80 | |
Day 2 | 62 (L) | NCS | 63–80 | ||
Day 4 | 58 (L) | NCS | 63–80 | ||
Day 6 | 64 | 63–80 | |||
Urinalysis | Ketones (mmol/L) | Screening | Negative | Negative | |
Day 1 | Trace (A) | NCS | Negative | ||
Day 2 | Trace (A) | NCS | Negative | ||
Day 4 | Negative | Negative | |||
Occult blood | Screening | Moderate (A) | NCS | Negative | |
Day 2 | Trace (A) | NCS | Negative | ||
Day 4 | Negative | Negative | |||
Protein-urines (g/L) | Screening | Trace (A) | NCS | Negative | |
Day 4 | Negative | Negative | |||
NCS – not clinically significant; A – abnormal; L – low. |